GFOR
Graf Acquisition Corp IV

65
Loading...
Loading...
NKGen Biotech, Inc. is a clinical-stage biotechnology company, which focuses on the development and commercialization of innovative autologous, allogeneic, and CAR-NK cell therapies utilizing a proprietary SNK platform. Its product candidates are based on a proprietary manufacturing and cryopreservation process which produces SNK cells that have high potency as defined by parameters such as cytotoxicity, cytokine production, and activating receptor expression. The company is headquartered in Santa Ana, CA.
Sector:
Finance
Industry:
Financial Conglomerates
Employees:
63

Frequently Asked Questions

What is Market Cap of NKGen Biotech Inc?
What is the 52-week high for NKGen Biotech Inc?
What is the 52-week low for NKGen Biotech Inc?
What is NKGen Biotech Inc stock price today?
What was NKGen Biotech Inc stock price yesterday?
What is the PE ratio of NKGen Biotech Inc?
What is the Price-to-Book ratio of NKGen Biotech Inc?
What is NKGen Biotech Inc's EBITDA?
What is the 50-day moving average of NKGen Biotech Inc?
How many employess does NKGen Biotech Inc has?

Latest GFOR News

View
No GFOR news at the moment.

Advertisement. Remove ads.

Advertisement. Remove ads.

Advertisement. Remove ads.